Cargando…

Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans

Since the inception of the IARC Monographs Programme in the early 1970s, this Programme has developed 119 Monograph Volumes on more than 1000 agents for which there exists some evidence of cancer risk to humans. Of these, 120 agents were found to meet the criteria for classification as carcinogenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Krewski, Daniel, Rice, Jerry M., Bird, Michael, Milton, Brittany, Collins, Brian, Lajoie, Pascale, Billard, Mélissa, Grosse, Yann, Cogliano, Vincent J., Caldwell, Jane C., Rusyn, Ivan I., Portier, Christopher J., Melnick, Ronald L., Baan, Robert A., Little, Julian, Zielinski, Jan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139235/
https://www.ncbi.nlm.nih.gov/pubmed/31795923
http://dx.doi.org/10.1080/10937404.2019.1642586
_version_ 1783518719850315776
author Krewski, Daniel
Rice, Jerry M.
Bird, Michael
Milton, Brittany
Collins, Brian
Lajoie, Pascale
Billard, Mélissa
Grosse, Yann
Cogliano, Vincent J.
Caldwell, Jane C.
Rusyn, Ivan I.
Portier, Christopher J.
Melnick, Ronald L.
Baan, Robert A.
Little, Julian
Zielinski, Jan M.
author_facet Krewski, Daniel
Rice, Jerry M.
Bird, Michael
Milton, Brittany
Collins, Brian
Lajoie, Pascale
Billard, Mélissa
Grosse, Yann
Cogliano, Vincent J.
Caldwell, Jane C.
Rusyn, Ivan I.
Portier, Christopher J.
Melnick, Ronald L.
Baan, Robert A.
Little, Julian
Zielinski, Jan M.
author_sort Krewski, Daniel
collection PubMed
description Since the inception of the IARC Monographs Programme in the early 1970s, this Programme has developed 119 Monograph Volumes on more than 1000 agents for which there exists some evidence of cancer risk to humans. Of these, 120 agents were found to meet the criteria for classification as carcinogenic to humans (Group 1). Volume 100 of the IARC Monographs, compiled in 2008–2009 and published in 2012, provided a review and update of the 107 Group 1 agents identified as of 2009. These agents were divided into six broad categories: (I) pharmaceuticals; (II) biological agents; (III) arsenic, metals, fibers and dusts; (IV) radiation; (V) personal habits and indoor combustions; and (VI) chemical agents and related occupations. The Group I agents reviewed in Volume 100, as well as five additional Group 1 agents defined in subsequent Volumes of the Monographs, were used to assess the degree of concordance between sites where tumors originate in humans and experimental animals including mice, rats, hamsters, dogs, and non-human primates using an anatomically based tumor nomenclature system, representing 39 tumor sites and 14 organ and tissue systems. This evaluation identified 91 Group 1 agents with sufficient evidence (82 agents) or limited evidence (9 agents) of carcinogenicity in animals. The most common tumors observed in both humans and animals were those of the respiratory system including larynx, lung, and lower respiratory tract. In humans, respiratory system tumors were noted for 31 of the 111 distinct Group 1 carcinogens identified up to and including Volume 109 of the IARC Monographs, comprising predominantly 14 chemical agents and related occupations in category VI; seven arsenic, metals, fibers, and dusts in category III, and five personal habits and indoor combustions in category V. Subsequent to respiratory system tumors, those in lymphoid and hematopoietic tissues (26 agents), the urothelium (18 agents), and the upper aerodigestive tract (16 agents) were most often seen in humans, while tumors in digestive organs (19 agents), skin (18 agents), and connective tissues (17 agents) were frequently seen in animals. Exposures to radiation, particularly X- and γ-radiation, and tobacco smoke were associated with tumors at multiple sites in humans. Although the IARC Monographs did not emphasize tumor site concordance between animals and humans, substantial concordance was detected for several organ and tissue systems, even under the stringent criteria for sufficient evidence of carcinogenicity used by IARC. Of the 60 agents for which at least one tumor site was identified in both humans and animals, 52 (87%) exhibited tumors in at least one of the same organ and tissue systems in humans and animals. It should be noted that some caution is needed in interpreting concordance at sites where sample size is particularly small. Although perfect (100%) concordance was noted for agents that induce tumors of the mesothelium, only two Group 1 agents that met the criteria for inclusion in the concordance analysis caused tumors at this site. Although the present analysis demonstrates good concordance between animals and humans for many, but not all, tumor sites, limitations of available data may result in underestimation of concordance.
format Online
Article
Text
id pubmed-7139235
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-71392352020-04-16 Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans Krewski, Daniel Rice, Jerry M. Bird, Michael Milton, Brittany Collins, Brian Lajoie, Pascale Billard, Mélissa Grosse, Yann Cogliano, Vincent J. Caldwell, Jane C. Rusyn, Ivan I. Portier, Christopher J. Melnick, Ronald L. Baan, Robert A. Little, Julian Zielinski, Jan M. J Toxicol Environ Health B Crit Rev Review Since the inception of the IARC Monographs Programme in the early 1970s, this Programme has developed 119 Monograph Volumes on more than 1000 agents for which there exists some evidence of cancer risk to humans. Of these, 120 agents were found to meet the criteria for classification as carcinogenic to humans (Group 1). Volume 100 of the IARC Monographs, compiled in 2008–2009 and published in 2012, provided a review and update of the 107 Group 1 agents identified as of 2009. These agents were divided into six broad categories: (I) pharmaceuticals; (II) biological agents; (III) arsenic, metals, fibers and dusts; (IV) radiation; (V) personal habits and indoor combustions; and (VI) chemical agents and related occupations. The Group I agents reviewed in Volume 100, as well as five additional Group 1 agents defined in subsequent Volumes of the Monographs, were used to assess the degree of concordance between sites where tumors originate in humans and experimental animals including mice, rats, hamsters, dogs, and non-human primates using an anatomically based tumor nomenclature system, representing 39 tumor sites and 14 organ and tissue systems. This evaluation identified 91 Group 1 agents with sufficient evidence (82 agents) or limited evidence (9 agents) of carcinogenicity in animals. The most common tumors observed in both humans and animals were those of the respiratory system including larynx, lung, and lower respiratory tract. In humans, respiratory system tumors were noted for 31 of the 111 distinct Group 1 carcinogens identified up to and including Volume 109 of the IARC Monographs, comprising predominantly 14 chemical agents and related occupations in category VI; seven arsenic, metals, fibers, and dusts in category III, and five personal habits and indoor combustions in category V. Subsequent to respiratory system tumors, those in lymphoid and hematopoietic tissues (26 agents), the urothelium (18 agents), and the upper aerodigestive tract (16 agents) were most often seen in humans, while tumors in digestive organs (19 agents), skin (18 agents), and connective tissues (17 agents) were frequently seen in animals. Exposures to radiation, particularly X- and γ-radiation, and tobacco smoke were associated with tumors at multiple sites in humans. Although the IARC Monographs did not emphasize tumor site concordance between animals and humans, substantial concordance was detected for several organ and tissue systems, even under the stringent criteria for sufficient evidence of carcinogenicity used by IARC. Of the 60 agents for which at least one tumor site was identified in both humans and animals, 52 (87%) exhibited tumors in at least one of the same organ and tissue systems in humans and animals. It should be noted that some caution is needed in interpreting concordance at sites where sample size is particularly small. Although perfect (100%) concordance was noted for agents that induce tumors of the mesothelium, only two Group 1 agents that met the criteria for inclusion in the concordance analysis caused tumors at this site. Although the present analysis demonstrates good concordance between animals and humans for many, but not all, tumor sites, limitations of available data may result in underestimation of concordance. Taylor & Francis 2019-12-03 /pmc/articles/PMC7139235/ /pubmed/31795923 http://dx.doi.org/10.1080/10937404.2019.1642586 Text en © 2019 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Review
Krewski, Daniel
Rice, Jerry M.
Bird, Michael
Milton, Brittany
Collins, Brian
Lajoie, Pascale
Billard, Mélissa
Grosse, Yann
Cogliano, Vincent J.
Caldwell, Jane C.
Rusyn, Ivan I.
Portier, Christopher J.
Melnick, Ronald L.
Baan, Robert A.
Little, Julian
Zielinski, Jan M.
Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans
title Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans
title_full Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans
title_fullStr Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans
title_full_unstemmed Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans
title_short Concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans
title_sort concordance between sites of tumor development in humans and in experimental animals for 111 agents that are carcinogenic to humans
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139235/
https://www.ncbi.nlm.nih.gov/pubmed/31795923
http://dx.doi.org/10.1080/10937404.2019.1642586
work_keys_str_mv AT krewskidaniel concordancebetweensitesoftumordevelopmentinhumansandinexperimentalanimalsfor111agentsthatarecarcinogenictohumans
AT ricejerrym concordancebetweensitesoftumordevelopmentinhumansandinexperimentalanimalsfor111agentsthatarecarcinogenictohumans
AT birdmichael concordancebetweensitesoftumordevelopmentinhumansandinexperimentalanimalsfor111agentsthatarecarcinogenictohumans
AT miltonbrittany concordancebetweensitesoftumordevelopmentinhumansandinexperimentalanimalsfor111agentsthatarecarcinogenictohumans
AT collinsbrian concordancebetweensitesoftumordevelopmentinhumansandinexperimentalanimalsfor111agentsthatarecarcinogenictohumans
AT lajoiepascale concordancebetweensitesoftumordevelopmentinhumansandinexperimentalanimalsfor111agentsthatarecarcinogenictohumans
AT billardmelissa concordancebetweensitesoftumordevelopmentinhumansandinexperimentalanimalsfor111agentsthatarecarcinogenictohumans
AT grosseyann concordancebetweensitesoftumordevelopmentinhumansandinexperimentalanimalsfor111agentsthatarecarcinogenictohumans
AT coglianovincentj concordancebetweensitesoftumordevelopmentinhumansandinexperimentalanimalsfor111agentsthatarecarcinogenictohumans
AT caldwelljanec concordancebetweensitesoftumordevelopmentinhumansandinexperimentalanimalsfor111agentsthatarecarcinogenictohumans
AT rusynivani concordancebetweensitesoftumordevelopmentinhumansandinexperimentalanimalsfor111agentsthatarecarcinogenictohumans
AT portierchristopherj concordancebetweensitesoftumordevelopmentinhumansandinexperimentalanimalsfor111agentsthatarecarcinogenictohumans
AT melnickronaldl concordancebetweensitesoftumordevelopmentinhumansandinexperimentalanimalsfor111agentsthatarecarcinogenictohumans
AT baanroberta concordancebetweensitesoftumordevelopmentinhumansandinexperimentalanimalsfor111agentsthatarecarcinogenictohumans
AT littlejulian concordancebetweensitesoftumordevelopmentinhumansandinexperimentalanimalsfor111agentsthatarecarcinogenictohumans
AT zielinskijanm concordancebetweensitesoftumordevelopmentinhumansandinexperimentalanimalsfor111agentsthatarecarcinogenictohumans